LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 19.69 | 84.90 | 6 | 1239 | 0.0048 | -0.4959 | MN20160318_Q02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 19.69 | 84.90 | 1244 | 1239 | 1.0037 | 1.0019 | MN20160318_Q02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 19.69 | 84.90 | 1445 | 1239 | 1.1659 | 1.0809 | MN20160318_Q02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 19.69 | 84.90 | 1544 | 1239 | 1.2457 | 1.1169 | MN20160318_Q02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 19.69 | 84.90 | 18 | 1239 | 0.0145 | -0.3304 | MN20160318_Q02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 19.69 | 84.90 | 1345 | 1239 | 1.0852 | 1.0427 | MN20160318_Q02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 21.40 | 84.90 | 8 | 1454 | 0.0055 | -0.4380 | MN20160318_Q02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 21.40 | 84.90 | 1237 | 1454 | 0.8504 | 0.9225 | MN20160318_Q02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 21.40 | 84.90 | 1519 | 1454 | 1.0442 | 1.0212 | MN20160318_Q02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 21.40 | 84.90 | 1602 | 1454 | 1.1013 | 1.0476 | MN20160318_Q02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 21.40 | 84.90 | 30 | 1454 | 0.0206 | -0.2241 | MN20160318_Q02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 21.40 | 84.90 | 1406 | 1454 | 0.9665 | 0.9835 | MN20160318_Q02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 23.10 | 84.90 | 13 | 1616 | 0.0080 | -0.3569 | MN20160318_Q02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 23.10 | 84.90 | 1262 | 1616 | 0.7808 | 0.8869 | MN20160318_Q02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 23.10 | 84.90 | 1574 | 1616 | 0.9739 | 0.9876 | MN20160318_Q02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 23.10 | 84.90 | 1631 | 1616 | 1.0091 | 1.0043 | MN20160318_Q02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 23.10 | 84.90 | 44 | 1616 | 0.0272 | -0.1433 | MN20160318_Q02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 23.10 | 84.90 | 1418 | 1616 | 0.8774 | 0.9394 | MN20160318_Q02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 24.81 | 84.90 | 17 | 1769 | 0.0096 | -0.3072 | MN20160318_Q02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 24.81 | 84.90 | 1344 | 1769 | 0.7595 | 0.8783 | MN20160318_Q02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 24.81 | 84.90 | 1644 | 1769 | 0.9291 | 0.9667 | MN20160318_Q02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 24.81 | 84.90 | 1706 | 1769 | 0.9641 | 0.9834 | MN20160318_Q02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 24.81 | 84.90 | 50 | 1769 | 0.0283 | -0.1138 | MN20160318_Q02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 24.81 | 84.90 | 1480 | 1769 | 0.8364 | 0.9201 | MN20160318_Q02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 26.51 | 84.90 | 25 | 1923 | 0.0130 | -0.2378 | MN20160318_Q02 | G13 |